Enterostatin (VPDPR) and its peptide fragment DPR reduce serum cholesterol levels after oral administration in mice

  • Takenaka Y
  • Nakamura F
  • Yamamoto T
 et al. 
  • 1


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.


We found that enterostatin (VPDPR), an anorexigenic peptide for a high-fat diet, significantly reduces serum cholesterol levels after oral administration of 100 mg/kg for 3 days in mice fed a high cholesterol-cholic acid diet. DPR, a peptide fragment of VPDPR, also had hypocholesterolemic activity at a dose of 50 mg/kg. Food intake was not suppressed under these dietary conditions. Fecal excretion of cholesterol and bile acids was increased significantly by both VPDPR and DPR. Interestingly, DPR induced hypocholesterolemic effects just two hours after a single oral administration at a dose of 100 mg/kg.

Author-supplied keywords

  • Administration, Oral
  • Animals
  • Cholesterol/analysis/*blood
  • Dietary Fats/administration & dosage
  • Feces/chemistry
  • Liver/chemistry/drug effects
  • Mice
  • Oligopeptides/administration & dosage/*pharmacolog
  • Peptide Fragments/administration & dosage/*pharmac
  • Research Support, Non-U.S. Gov't

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Y Takenaka

  • F Nakamura

  • T Yamamoto

  • M Yoshikawa

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free